From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Compound class:
Synthetic organic
Comment: MRL-248 is a selective, small molecule antagonist of RORγt, an isoform of RORγ (RAR related orphan receptor C), with antiinflammatory potential [1].
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
| MRL-248-induced inhbition of RORγt reduces pro-inflammatory IL-17A secretion from TH17 cells from patients with four inflammatory conditions (ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and inflammatory bowel disease), and reduces transcription of TH17-associated genes [1]. |